Clinical Trials at Mount Sinai
As of August 2026, 41 paid clinical trials are recruiting at Mount Sinai, located at 5 E 98TH ST, BOX 1188, NEW YORK, NY 10029-6501, phone (646) 387-1517 in New York, New York. Active studies at this site cover conditions such as Breast Cancer, Prostate Cancer and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in New York
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
42 clinical trials at Mount Sinai
·Clear filters·A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
ELEVATE High-Risk PCI Pivotal Study
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
US National OCS Heart Perfusion (OHP) Registry
A Study of PHST001 in Advanced Solid Tumors
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
The Tether™ - Vertebral Body Tethering System Post Approval Study
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area
MMA Embolization for Refractory Chronic Migraine
EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures
Enhancing Heart Allograft Function With the OCS Heart System Trial
A Long Term Follow-up Study of TScan TCR-T Products
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
Low Dose IL-2 for the Treatment of Crohn's Disease
Kidney Precision Medicine Project
JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction
Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas
Biologics And Clinical Immunology Cohort at Sinai
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Parkinson's Foundation PD GENEration Genetic Registry
Topical 0.5% Timolol Solution for Healing Lower Extremity Wounds
PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
Common conditions studied in New York
- Breast Cancer (92 active studies)
- Prostate Cancer (74 active studies)
- Multiple Myeloma (45 active studies)
- Colorectal Cancer (42 active studies)
- Ovarian Cancer (42 active studies)
- Endometrial Cancer (37 active studies)
Leading research sponsors in New York
- Memorial Sloan Kettering Cancer Center
- NYU Langone Health
- Columbia University
- Icahn School of Medicine at Mount Sinai
- Weill Medical College of Cornell University
Frequently asked questions
How many paid clinical trials are currently recruiting in New York?
There are approximately 3,389 recruiting clinical trials in New York, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New York pay participants?
Most recruiting trials in New York compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New York?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New York?
The most common conditions under active study in New York include Breast Cancer (92), Prostate Cancer (74), Multiple Myeloma (45), Colorectal Cancer (42), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New York?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New York on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New York?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New York?
Recruiting research sites in New York include Memorial Sloan Kettering Cancer Center, NYU Langone Health, Icahn School of Medicine at Mount Sinai, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New York right now?
The largest active categories in New York are Cancer & tumors (1,136), Neurology & pain (198), Cardiovascular (194). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Mount Sinai?
Mount Sinai is located at 5 E 98TH ST, BOX 1188, NEW YORK, NY 10029-6501. Use the Google Maps link in the intro above to get directions.
How do I contact Mount Sinai?
You can reach Mount Sinai by phone at (646) 387-1517. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.